NovaBridge Biosciences (NBP) Capital expenditures 2019–2025
NovaBridge Biosciences (NBP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$7,000FY2025 · since FY2019: $1.8M → $7,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7,000 | -85.4% |
| FY2024 | $48,000 | -70.7% |
| FY2023 | $164,000 | -92.2% |
| FY2022 | $2.1M | -55.5% |
| FY2021 | $4.7M | +282.8% |
| FY2020 | $1.2M | -30.2% |
| FY2019 | $1.8M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice